ZFHX4 and central nervous system cancer: This conclusion is supported by both our bioinformatics analysis and direct experimental validation, which showed that ZFHX4-AS1 is significantly overexpressed in glioma tissues, and its high expression is associated with poor patient prognosis and higher tumor malignancy.